JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
|
+$1.58B |
| 2 |
Vanguard FTSE Europe ETF
VGK
|
+$1B |
| 3 |
CPGX
COLUMBIA PIPELINE GROUP IN COM STK (DE)
CPGX
|
+$958M |
| 4 |
Eli Lilly
LLY
|
+$776M |
| 5 |
AGN
Allergan plc
AGN
|
+$751M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.23B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.98B |
| 3 |
Johnson & Johnson
JNJ
|
+$1.31B |
| 4 |
Merck
MRK
|
+$837M |
| 5 |
Bread Financial
BFH
|
+$630M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.93% |
| 2 | Healthcare | 11.41% |
| 3 | Technology | 10.89% |
| 4 | Consumer Discretionary | 8.56% |
| 5 | Industrials | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
WisdomTree Japan Hedged Equity Fund
DXJ
$7.42B
| $606M | 0.16% |
12,463,018
+10,774,886
| +638% | +$583M |
|
152
Kimco Realty
KIM
$16.4B
| $605M | 0.16% |
24,767,994
+10,696,555
| +76% | +$257M |
|
153
Boston Scientific
BSX
$71.5B
| $604M | 0.16% |
36,786,889
-17,167,838
| -32% | -$293M |
|
|
SCHW
154
Charles Schwab
SCHW
$187B
| $598M | 0.16% |
20,955,657
+2,603,674
| +14% | +$83.6M |
|
155
PUT
iShares MSCI Australia ETF
EWA
$1.48B
| $598M | 0.16% |
26,394,612
-6,326,288
| -19% | -$124M |
|
156
Infosys
INFY
$50.7B
| $591M | 0.16% |
61,962,502
-251,966
| -0.4% | -$2.15M |
|
157
Booking.com
BKNG
$161B
| $582M | 0.16% |
11,769,575
-1,550,225
| -12% | -$77M |
|
158
Genuine Parts
GPC
$18.7B
| $579M | 0.15% |
6,983,650
+1,842,324
| +36% | +$159M |
|
159
Phillips 66
PSX
$81.4B
| $577M | 0.15% |
7,506,158
-2,321,072
| -24% | -$184M |
|
160
Ford
F
$55.7B
| $576M | 0.15% |
42,445,613
+9,019,393
| +27% | +$129M |
|
161
M&T Bank
MTB
$36.2B
| $568M | 0.15% |
4,655,208
-38,934
| -0.8% | -$4.87M |
|
162
Kohl's
KSS
$2.19B
| $551M | 0.15% |
11,897,820
-215,518
| -2% | -$12.1M |
|
163
Arrow Electronics
ARW
$10.4B
| $550M | 0.15% |
9,951,309
+1,193,400
| +14% | +$66.3M |
|
164
LyondellBasell Industries
LYB
$19.2B
| $549M | 0.15% |
6,590,191
-551,763
| -8% | -$49.1M |
|
165
BioMarin Pharmaceuticals
BMRN
$12.4B
| $543M | 0.15% |
5,158,203
+2,438,282
| +90% | +$326M |
|
166
Northrop Grumman
NOC
$81.2B
| $542M | 0.14% |
3,264,609
+813,534
| +33% | +$136M |
|
167
Enterprise Products Partners
EPD
$81.7B
| $539M | 0.14% |
21,663,327
-3,132,584
| -13% | -$86.9M |
|
168
3M
MMM
$94.3B
| $538M | 0.14% |
4,538,851
+288,426
| +7% | +$35.5M |
|
169
GSK
GSK
$106B
| $536M | 0.14% |
11,147,475
+3,757,372
| +51% | +$196M |
|
|
WBA
170
DELISTED
Walgreens Boots Alliance
WBA
| $535M | 0.14% |
6,436,280
+298,777
| +5% | +$27M |
|
171
Prudential Financial
PRU
$41.8B
| $534M | 0.14% |
7,009,807
-738,615
| -10% | -$62M |
|
172
VF Corp
VFC
$5.89B
| $527M | 0.14% |
8,206,187
+127,876
| +2% | +$8.76M |
|
173
Qualcomm
QCOM
$176B
| $520M | 0.14% |
9,676,083
-1,310,683
| -12% | -$77.9M |
|
174
Oracle
ORCL
$423B
| $517M | 0.14% |
14,313,271
-6,335,573
| -31% | -$244M |
|
|
WRK
175
DELISTED
WestRock Company
WRK
| $516M | 0.14% |
+11,127,011
| New | +$596M |
|
Similar funds
JP Morgan Chase's Q3 2015 Portfolio in Review
As of Q3 2015, JP Morgan Chase held 4,367 positions worth $374B, down 12% from $424B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase withdrew a net $14B in Q3 2015, closing 488 positions and reducing 1,582 holdings. Its most notable exit was ROCK-TENN COMPANY CL-A, an estimated $559M position sold in full.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.
Against the trend, JP Morgan Chase opened a new position in COLUMBIA PIPELINE GROUP IN COM STK (DE) worth $672M.
- JP Morgan Chase's largest Q3 2015 buy was COLUMBIA PIPELINE GROUP IN COM STK (DE): 36,762,567 shares worth $672M.
- JP Morgan Chase added most to Xtrackers MSCI EAFE Hedged Equity ETF in Q3 2015, an estimated $1.58B increase.
- JP Morgan Chase's biggest Q3 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.23B.
- JP Morgan Chase fully exited ROCK-TENN COMPANY CL-A in Q3 2015, selling an estimated $559M.
- JP Morgan Chase's ten largest holdings make up 17% of its $374B portfolio in Q3 2015.
- JP Morgan Chase opened 374 new positions and closed 488 in Q3 2015.
- JP Morgan Chase's portfolio value fell 12% quarter-over-quarter to $374B.
Based on JP Morgan Chase's 13F filing for Q3 2015, filed 13 Nov 2015.